<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01326650</url>
  </required_header>
  <id_info>
    <org_study_id>004</org_study_id>
    <nct_id>NCT01326650</nct_id>
  </id_info>
  <brief_title>Vitamin D and Mortality in Heart Failure</brief_title>
  <acronym>EVITA</acronym>
  <official_title>Effect of Vitamin D on All-cause Mortality in Heart Failure Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heart and Diabetes Center North-Rhine Westfalia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heart and Diabetes Center North-Rhine Westfalia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite significant therapeutic improvements, congestive heart failure (CHF) patients still
      have a poor prognosis. Currently, 5-year survival rates are only 35-50%. There is an
      accumulating body of evidence from prospective cohort studies that low circulating
      25-hydroxyvitamin D is an independent predictor of all-cause and cardiovascular mortality,
      respectively. Vitamin D deficiency is prevalent among CHF patients. We hypothesize that
      vitamin D may improve survival in CHF patients. We therefore aimed to investigate whether
      vitamin D supplementation reduces mortality and increases event-free survival in end-stage
      CHF patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who died during the intervention</measure>
    <time_frame>three years</time_frame>
    <description>all-cause mortality (any cause of death) will be assessed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of event-free survivors</measure>
    <time_frame>three years</time_frame>
    <description>event defined as: cardiac transplantation, high urgent listing for cardiac transplantation, resuscitation, ventricular assist device Implantation, hypercalcemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in biochemical risk markers</measure>
    <time_frame>three years</time_frame>
    <description>inflammation markers, kidney parameters, lipid parameters, haemostasis parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with elevated safety parameters</measure>
    <time_frame>every 6 months</time_frame>
    <description>Serum 25-Hydroxyvitamin D should not exceed 150 ng/ml.
Serum calcium should not exceed 2.75 mmol/l.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>Vitamin D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>daily vitamin D supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>daily placebo supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>daily oral vitamin D supplement of 100 micrograms for three years</description>
    <arm_group_label>Vitamin D</arm_group_label>
    <other_name>solution of vitamin D oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>daily oral placebo supplement for three years</description>
    <arm_group_label>placebo</arm_group_label>
    <other_name>solution of migliol oil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years of age and &lt; 80 years of age

          -  New York Heart Association Functional Class &gt; = II

        Exclusion Criteria:

          -  pregnancy and lactation

          -  sarcoidosis

          -  daily vitamin D intake &gt; 20 micrograms

          -  serum 25-hydroxyvitamin D &gt; 30 ng/ml

          -  hypercalcemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Armin Zittermann, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Center North Rhine-Westphalia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jochen Börgermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Center North Rhine-Westphalia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Center North Rhine-Westphalia</name>
      <address>
        <city>Bad Oeynhausen</city>
        <state>Federal State of North Rhine-Westphalia</state>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Zittermann A, Schleithoff SS, Frisch S, Götting C, Kuhn J, Koertke H, Kleesiek K, Tenderich G, Koerfer R. Circulating calcitriol concentrations and total mortality. Clin Chem. 2009 Jun;55(6):1163-70. doi: 10.1373/clinchem.2008.120006. Epub 2009 Apr 9.</citation>
    <PMID>19359534</PMID>
  </reference>
  <reference>
    <citation>Zittermann A, Frisch S, Berthold HK, Götting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr. 2009 May;89(5):1321-7. doi: 10.3945/ajcn.2008.27004. Epub 2009 Mar 25.</citation>
    <PMID>19321573</PMID>
  </reference>
  <reference>
    <citation>Zittermann A, Schleithoff SS, Götting C, Fuchs U, Kuhn J, Kleesiek K, Tenderich G, Koerfer R. Calcitriol deficiency and 1-year mortality in cardiac transplant recipients. Transplantation. 2009 Jan 15;87(1):118-24. doi: 10.1097/TP.0b013e31818c2708.</citation>
    <PMID>19136901</PMID>
  </reference>
  <reference>
    <citation>Zittermann A, Schleithoff SS, Götting C, Dronow O, Fuchs U, Kuhn J, Kleesiek K, Tenderich G, Koerfer R. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail. 2008 Mar;10(3):321-7. doi: 10.1016/j.ejheart.2008.01.013. Epub 2008 Mar 4.</citation>
    <PMID>18304873</PMID>
  </reference>
  <reference>
    <citation>Zittermann A, Fischer J, Schleithoff SS, Tenderich G, Fuchs U, Koerfer R. Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int J Vitam Nutr Res. 2007 Jul;77(4):280-8.</citation>
    <PMID>18271283</PMID>
  </reference>
  <reference>
    <citation>Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006 Apr;83(4):754-9.</citation>
    <PMID>16600924</PMID>
  </reference>
  <reference>
    <citation>Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Körfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003 Jan 1;41(1):105-12.</citation>
    <PMID>12570952</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2011</study_first_submitted>
  <study_first_submitted_qc>March 30, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 31, 2011</study_first_posted>
  <last_update_submitted>August 10, 2016</last_update_submitted>
  <last_update_submitted_qc>August 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D, mortality, event-free survival, heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

